These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 9853920

  • 1. Serum levels of basic fibroblast growth factor and vascular endothelial growth factor in children and adolescents with type 1 diabetes mellitus.
    Malamitsi-Puchner A, Sarandakou A, Tziotis J, Dafogianni C, Bartsocas CS.
    Pediatr Res; 1998 Dec; 44(6):873-5. PubMed ID: 9853920
    [Abstract] [Full Text] [Related]

  • 2. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
    Tabone MD, Landman-Parker J, Arcil B, Coudert MC, Gerota I, Benbunan M, Leverger G, Dosquet C.
    Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
    [Abstract] [Full Text] [Related]

  • 3. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
    Robak E, Woźniacka A, Sysa-Jedrzejowska A, Stepień H, Robak T.
    Eur Cytokine Netw; 2001 Mar; 12(3):445-52. PubMed ID: 11566625
    [Abstract] [Full Text] [Related]

  • 4. Microvascular permeability is increased in both types of diabetes and correlates differentially with serum levels of insulin-like growth factor I (IGF-I) and vascular endothelial growth factor (VEGF).
    Brausewetter F, Jehle PM, Jung MF, Boehm BO, Brueckel J, Hombach V, Osterhues HH.
    Horm Metab Res; 2001 Dec; 33(12):713-20. PubMed ID: 11753756
    [Abstract] [Full Text] [Related]

  • 5. Heparin-binding angiogenic factors (basic fibroblast growth factor and vascular endothelial growth factor) in early neonatal life.
    Malamitsi-Puchner A, Tziotis J, Protonotariou E, Xyni K, Sarandakou A, Creatsas G.
    Pediatr Res; 1999 Jun; 45(6):877-80. PubMed ID: 10367782
    [Abstract] [Full Text] [Related]

  • 6. Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients.
    Brattström D, Bergqvist M, Larsson A, Holmertz J, Hesselius P, Rosenberg L, Brodin O, Wagenius G.
    Anticancer Res; 1998 Jun; 18(2A):1123-7. PubMed ID: 9615776
    [Abstract] [Full Text] [Related]

  • 7. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG, Passam FH, Boula A, Christophoridou A, Aloizos G, Roussou P, Kyriakou DS.
    Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
    [Abstract] [Full Text] [Related]

  • 8. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
    Di Raimondo F, Azzaro MP, Palumbo G, Bagnato S, Giustolisi G, Floridia P, Sortino G, Giustolisi R.
    Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
    [Abstract] [Full Text] [Related]

  • 9. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.
    Salgado R, Vermeulen PB, Benoy I, Weytjens R, Huget P, Van Marck E, Dirix LY.
    Br J Cancer; 1999 May; 80(5-6):892-7. PubMed ID: 10360671
    [Abstract] [Full Text] [Related]

  • 10. Correlation between carotid artery distensibility and serum vascular endothelial growth factor concentrations in type 1 diabetic subjects and nondiabetic subjects.
    Valabhji J, Dhanjil S, Nicolaides AN, Elkeles RS, Sharp P.
    Metabolism; 2001 Jul; 50(7):825-9. PubMed ID: 11436189
    [Abstract] [Full Text] [Related]

  • 11. Angiogenic protein expression in advanced epithelial ovarian cancer.
    Barton DP, Cai A, Wendt K, Young M, Gamero A, De Cesare S.
    Clin Cancer Res; 1997 Sep; 3(9):1579-86. PubMed ID: 9815846
    [Abstract] [Full Text] [Related]

  • 12. [Assessment of growth factor levels in adolescents with type 1 diabetes mellitus and the beginning of diabetic microangiopathy].
    Peczyńska J, Urban M, Urban B, Głowińska B, Florys B.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004 Sep; 10(1):41-8. PubMed ID: 15355738
    [Abstract] [Full Text] [Related]

  • 13. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C, Coudert MC, Lepage E, Cabane J, Richard F.
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [Abstract] [Full Text] [Related]

  • 14. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
    Aguayo A, Kantarjian HM, Estey EH, Giles FJ, Verstovsek S, Manshouri T, Gidel C, O'Brien S, Keating MJ, Albitar M.
    Cancer; 2002 Nov 01; 95(9):1923-30. PubMed ID: 12404286
    [Abstract] [Full Text] [Related]

  • 15. Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with carcinoma and sarcoma.
    Linder C, Linder S, Munck-Wikland E, Strander H.
    Anticancer Res; 1998 Nov 01; 18(3B):2063-8. PubMed ID: 9677468
    [Abstract] [Full Text] [Related]

  • 16. Vascular endothelial growth factor and basic fibroblast growth factor are found in resolving venous thrombi.
    Waltham M, Burnand KG, Collins M, Smith A.
    J Vasc Surg; 2000 Nov 01; 32(5):988-96. PubMed ID: 11054231
    [Abstract] [Full Text] [Related]

  • 17. Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and soluble interleukin-2 receptor (sIL-2R) concentrations in peripheral blood as markers of pituitary tumours.
    Komorowski J, Jankewicz J, Stepień H.
    Cytobios; 2000 Nov 01; 101(398):151-9. PubMed ID: 10755214
    [Abstract] [Full Text] [Related]

  • 18. Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver mestastasis vascularity and volume.
    Davies MM, Jonas SK, Kaur S, Allen-Mersh TG.
    Br J Cancer; 2000 Mar 01; 82(5):1004-8. PubMed ID: 10737380
    [Abstract] [Full Text] [Related]

  • 19. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.
    Burgos R, Simó R, Audí L, Mateo C, Mesa J, García-Ramírez M, Carrascosa A.
    Diabetologia; 1997 Sep 01; 40(9):1107-9. PubMed ID: 9300249
    [Abstract] [Full Text] [Related]

  • 20. A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis.
    Braybrooke JP, O'Byrne KJ, Propper DJ, Blann A, Saunders M, Dobbs N, Han C, Woodhull J, Mitchell K, Crew J, Smith K, Stephens R, Ganesan TS, Talbot DC, Harris AL.
    Clin Cancer Res; 2000 Dec 01; 6(12):4697-704. PubMed ID: 11156222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.